Spotlight on Agalsidase Beta in Fabry Disease.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 269, doi. 10.2165/00063030-200721040-00007
- By:
- Publication type:
- Article
Works matching IS 11738804 AND DT 2007 AND VI 21 AND IP 4
Results: 7
1
2
Biotechnology and the Treatment of Addictive Disorders.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 259, doi. 10.2165/00063030-200721040-00006
- By:
- Publication type:
- Article
3
Emerging Therapies for the Treatment of Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 245, doi. 10.2165/00063030-200721040-00005
- By:
- Publication type:
- Article
4
Locked Nucleic Acid Oligonucleotides: The Next Generation of Antisense Agents?
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 235, doi. 10.2165/00063030-200721040-00004
- By:
- Publication type:
- Article
5
Targeting Mitosis for Anti-Cancer Therapy.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 225, doi. 10.2165/00063030-200721040-00003
- By:
- Publication type:
- Article
6
Molecularly Targeted Therapeutics for Breast Cancer.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 215, doi. 10.2165/00063030-200721040-00002
- By:
- Publication type:
- Article
7
Targeting Angiogenesis in Advanced Breast Cancer.
- Published in:
- BioDrugs, 2007, v. 21, n. 4, p. 209, doi. 10.2165/00063030-200721040-00001
- By:
- Publication type:
- Article